Benchmarks edge lower as COVID-19 fears re-escalate; Nifty below 17,200
The domestic indices tanked during morning trade after media reports suggested that a new coronavirus variant has a spike protein that is 'dramatically different' to the one which vaccines are based on, raising fears it could evade the immune response.